Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

Your search for ‘Fulbright & Jaworski LLP’ returned 961 results

Use advanced search filters to refine your search

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Whither Tech M&A 2016?

    According to a recent MergerMarket Group report, the first 11 months of 2015 saw global deal value reach USD $3.88tn, surpassing global deal value for the entirety of 2014.
    CanadaCorporate/Commercial Law
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Pharma In Brief - Federal Court Grants One Of Three Prohibition Applications For VIGAMOX® Eye Drops Containing Moxifloxacin Hydrochloride

    This latest decision from the Federal Court is consistent with a recent trend towards a more literal construction of patent claims.
    CanadaIntellectual Property
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
Article

Forecasts Subject To Part XXIII.1 Claims, But Common Law Misrepresentation Found Not To Be Preferable Procedure

On February 19, 2014, the Ontario Superior Court released its decision in Trustees of the Millwright Regional Council of Ontario Pension Trust Fund v Celestica Inc.
CanadaCorporate/Commercial Law
Norton Rose Fulbright Canada LLP
Norton Rose Fulbright Canada LLP
  • Article

    Ontario And Quebec Make Strides In Updating Their Mining Regimes

    This is a transition period for Ontario's regulatory regime—one that requires patience, goodwill, education and the on-going co-operation of all parties if the reforms are to achieve the positive results the government is hoping for.
    CanadaEnergy and Natural Resources
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Pharma In Brief: No Ontario Court Section 8 Claim For Unjust Enrichment

    On September 12, 2013, the Ontario Court of Appeal ("ONCA") issued its decision in Apotex Inc. v. Abbott Laboratories, Limited 2013 ONCA 555 ("Abbott").
    CanadaFood, Drugs, Healthcare, Life Sciences
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Pharma In Brief - Federal Court Considers Functional Antibody Claims Valid And Infringed

    The Federal Court has issued the first decision in Canada addressing the alleged infringement and validity of humanized antibody claims.
    CanadaIntellectual Property
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Pharma In Brief - Patents Found Obvious; Subsequent Appeal Moot

    The only issue before the Court in both proceedings was whether Teva's allegation of invalidity based on obviousness was justified.
    CanadaIntellectual Property
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Solicitor-Client Privilege Trumps Federal Anti-Terrorist Laws

    The Supreme Court of Canada recently struck down sections of the federal terrorist financing and money laundering law because it violated solicitor-client privilege.
    CanadaLitigation, Mediation & Arbitration
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Le Code Civil Du Québec Au Secours De La Cour Fédérale

    Que l'on considère son système gouvernemental ou juridique, le Canada semble parfois être un pays schizophrène.
    CanadaIntellectual Property
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    TSX Issues Staff Notice On Emerging Market Issuers

    Following its 2012 public consultation on emerging market issuers the Toronto Stock Exchange has published a staff notice on the application of the TSX original and continued listing requirements to EMIs.
    CanadaCorporate/Commercial Law
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Alberta Amends PIPA To Address Concerns Between Freedom Of Expression And Privacy – But Only During Labour Disputes

    Alberta's amendments to the Personal Information Protection Act have narrowly addressed the Supreme Court of Canada's concerns about the appropriate balance between freedom of expression and rights to privacy.
    CanadaEmployment and HR
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Refuser De Se Déplacer À L’étranger Dans Le Cadre De Son Travail Peut Mener À Un Congédiement

    Dans Gagnon c C2C inc.1, la Cour d’appel du Québec confirme le congédiement du président d’une société minière basée au Québec ayant refusé de se rendre à l’étranger à la demande de son conseil d’administration afin de régulariser la situation avec un partenaire local.
    CanadaEmployment and HR
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Anti-Money Laundering: Long-Awaited Regulatory Amendments

    On July 4, 2015, proposed amendments to various regulations under the Proceeds of Crime (Money Laundering) and Terrorist Financing Act (PC Act) were published in the Canada Gazette.
    CanadaFinance and Banking
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Pharma In Brief - Canada: Section 8: Federal Court Provides Insight Into The Determination Of Damages In The Hypothetical Market

    On December 11, 2013 the Federal Court released an important decision pertaining to the determination of damages under section 8 of the Patented Medicines (Notice of Compliance) Regulations (the Regulations).
    CanadaFood, Drugs, Healthcare, Life Sciences
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Pharma In Brief - Quebec Amends Its Code Of Ethics Of Physicians

    The Collège des médecins du Québec (the CMQ) has made various changes to the Code of ethics of physicians (the Code) to address physicians independence and impartiality, issues related to new technologies, and respond to requests regarding the accessibility of medical records.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    A Roadmap For IP Protection Strategies For Oil And Gas Technologies

    Owing to the depletion of existing resources and geopolitical factors, participants in the energy marketplace are searching for alternatives to crude oil originating from the Gulf states. This is further incentivizing the exploration for and development, production and upgrading of untapped oil and gas resources, especially unconventional reserves.
    CanadaIntellectual Property
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    L’Union Ne Fait Plus La Force : Une Décision De La Cour Suprême Consacre L’Éparpillement Des Auteurs

    La Cour Suprême a publié aujourd’hui les motifs de sa décision dans l’affaire CAR-FAC / RAAV contre le Musée des Beaux-Arts du Canada.
    CanadaIntellectual Property
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    La Cour D’Appel Du Québec Confirme Que Les Lois Et Règlements D’Ordre Public Applicables Aux Contrats Réglementés Ne Constituent Pas Des Clauses Externes

    Le 29 janvier 2015, la Cour suprême du Canada a refusé la demande d’autorisation d’en appeler du jugement de la Cour d’appel du Québec rendu le 30 mai 2014.
    CanadaCorporate/Commercial Law
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Un Baume Pour Les Administrateurs : Rejet D’une Action En L’absence D’allégations Reprochant Une Faute Personnelle Aux Administrateurs D’une Personne Morale

    La Cour d’appel a refusé d’accorder la permission d’appeler de cette décision le 19 novembre 2014.
    CanadaCorporate/Commercial Law
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Pharma In Brief - Canada: Merck Awarded Substantial Damages For Infringement Of Lovastatin Patent

    The Federal Court held that Merck and Co., Inc. ("Merck US") and Merck Canada Inc. ("Merck Canada") (collectively "Merck") are entitled to $119,054,327 in damages plus pre and post judgment interest arising from Apotex Inc.’s ("Apotex") infringement of Canadian Patent No 1,161,380 (the "‘380 Patent") with respect to the anti-cholesterol drug MEVACOR (lovastatin).
    CanadaFood, Drugs, Healthcare, Life Sciences
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Showing 881–900 of 961 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics